Weekly Recap: CoughLess Trezmi NDA filing and ralinepag PDUFA

United Therapeutics Corporation (NASDAQ:UTHR) is advancing multiple pulmonary and transplant programs—filing an NDA this year for inhaled CoughLess Trezmi with launch planned next year, pursuing ralinepag and Tyvaso dry—powder versions, scaling xenokidney transplants—while facing a new Sell from Go…